Provided by Tiger Trade Technology Pte. Ltd.

Invesco Zacks Multi-Asset Income ETF

30.41
-0.1551-0.51%
Volume:883
Turnover:26.87K
Market Cap:125.01M
PE:- -
High:30.41
Open:30.41
Low:30.41
Close:30.57
52wk High:30.65
52wk Low:25.81
Shares:4.11M
Float Shares:4.11M
Volume Ratio:0.69
T/O Rate:0.02%
Dividend:1.24
Dividend Rate:4.09%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

New York Closing Stocks

Dow Jones
·
Aug 15

Jianzhi Education Technology Launches $5.4 Million ADS Offering to Bolster Operations

TIPRANKS
·
Aug 14

Mizuho Securities Remains a Buy on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 14

Anheuser-Busch InBev S.A. ADR Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 14

Ascentage Pharma Corrects Timing for August 19, 2026 Interim Results Webcast

TIPRANKS
·
Aug 13

Copel Board Approves R$706 Million Interest on Equity and 2025 Form 20-F Filing

TIPRANKS
·
Aug 13

Asian Companies Raise $28 Billion via ADRs in 2024, Marking a Six-Year High, as AI Boom and Valuation Gaps Drive Listings

Stock News
·
Aug 13

Anheuser-Busch InBev S.A. ADR Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Aug 13

New York Closing Stocks

Dow Jones
·
Aug 13

Stocks Ex-Dividend August 14

Dow Jones
·
Aug 13

Haleon’s New Gum‑Health Toothpaste Trial: What Investors Should Watch

TIPRANKS
·
Aug 13

Cantor Fitzgerald Reaffirms Their Buy Rating on Belite Bio, Inc. ADR (BLTE)

TIPRANKS
·
Aug 12

Kaspi.kz Posts Strong H1 2026 Revenue Growth as Costs Hold Profit Flat

TIPRANKS
·
Aug 12

Yi Chen Raises Approval Odds and Lifts Tinlarebant-Focused 12‑Month Price Target to $214 While Reiterating Buy Rating

TIPRANKS
·
Aug 12

NYSE Net Change Percentage Gainers & Losers

Dow Jones
·
Aug 12

NYSE Most Active Issues

Dow Jones
·
Aug 12

Anheuser-Busch InBev S.A. ADR Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Belite Bio Wins FDA Priority Review for Tinlarebant in Stargardt Disease

TIPRANKS
·
Aug 12

Cboe data shows mixed options sentiment in SK Hynix Inc – ADR with shares up 3.07%

TIPRANKS
·
Aug 12

Copel Board Approves Q2 2026 Results and BNDES-Backed R$4 Billion Financing Plan

TIPRANKS
·
Aug 12